NZ607670A - Theobromine in combination with an expectorant or a mucolytic for use in therapy - Google Patents
Theobromine in combination with an expectorant or a mucolytic for use in therapyInfo
- Publication number
- NZ607670A NZ607670A NZ607670A NZ60767011A NZ607670A NZ 607670 A NZ607670 A NZ 607670A NZ 607670 A NZ607670 A NZ 607670A NZ 60767011 A NZ60767011 A NZ 60767011A NZ 607670 A NZ607670 A NZ 607670A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mucolytic
- expectorant
- guaiacol
- iodide
- theobromine
- Prior art date
Links
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003172 expectorant agent Substances 0.000 title abstract 3
- 230000003419 expectorant effect Effects 0.000 title abstract 3
- 230000000510 mucolytic effect Effects 0.000 title abstract 3
- 229960004559 theobromine Drugs 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 abstract 3
- OMDMTHRBGUBUCO-IUCAKERBSA-N (1s,5s)-5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol Chemical compound CC1=CC[C@H](C(C)(C)O)C[C@@H]1O OMDMTHRBGUBUCO-IUCAKERBSA-N 0.000 abstract 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 abstract 2
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 abstract 2
- 229960005174 ambroxol Drugs 0.000 abstract 2
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 abstract 2
- 239000001099 ammonium carbonate Substances 0.000 abstract 2
- 229960003870 bromhexine Drugs 0.000 abstract 2
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 abstract 2
- 229960004399 carbocisteine Drugs 0.000 abstract 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 abstract 2
- 229960004224 tyloxapol Drugs 0.000 abstract 2
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 abstract 2
- 229920001664 tyloxapol Polymers 0.000 abstract 2
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (S)-(-)-verbenone Chemical compound CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 abstract 1
- PVKUHCBHOUMGJN-UHFFFAOYSA-N 1,3-dimethyl-7h-purine-2,6-dione;3-(2-methoxyphenoxy)propane-1,2-diol Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2.COC1=CC=CC=C1OCC(O)CO PVKUHCBHOUMGJN-UHFFFAOYSA-N 0.000 abstract 1
- WHRZCXAVMTUTDD-UHFFFAOYSA-N 1h-furo[2,3-d]pyrimidin-2-one Chemical compound N1C(=O)N=C2OC=CC2=C1 WHRZCXAVMTUTDD-UHFFFAOYSA-N 0.000 abstract 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 abstract 1
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 abstract 1
- 244000284152 Carapichea ipecacuanha Species 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 abstract 1
- 239000009471 Ipecac Substances 0.000 abstract 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
- 235000006173 Larrea tridentata Nutrition 0.000 abstract 1
- 244000073231 Larrea tridentata Species 0.000 abstract 1
- WHOHXJZQBJXAKL-DFWYDOINSA-N Mecysteine hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CS WHOHXJZQBJXAKL-DFWYDOINSA-N 0.000 abstract 1
- XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 abstract 1
- 102000016943 Muramidase Human genes 0.000 abstract 1
- 108010014251 Muramidase Proteins 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 244000303379 Styrax officinalis Species 0.000 abstract 1
- 235000001361 Styrax officinalis Nutrition 0.000 abstract 1
- YTGJWQPHMWSCST-UHFFFAOYSA-N Tiopronin Chemical compound CC(S)C(=O)NCC(O)=O YTGJWQPHMWSCST-UHFFFAOYSA-N 0.000 abstract 1
- 108010058907 Tiopronin Proteins 0.000 abstract 1
- 241000219793 Trifolium Species 0.000 abstract 1
- 229960004308 acetylcysteine Drugs 0.000 abstract 1
- 229940048732 althea root Drugs 0.000 abstract 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 abstract 1
- 235000012501 ammonium carbonate Nutrition 0.000 abstract 1
- 229940059913 ammonium carbonate Drugs 0.000 abstract 1
- 229960001040 ammonium chloride Drugs 0.000 abstract 1
- 235000019270 ammonium chloride Nutrition 0.000 abstract 1
- 229960001283 antimony pentasulfide Drugs 0.000 abstract 1
- PPKVREKQVQREQD-UHFFFAOYSA-N antimony pentasulfide Chemical compound S=[Sb](=S)S[Sb](=S)=S PPKVREKQVQREQD-UHFFFAOYSA-N 0.000 abstract 1
- 229940050390 benzoate Drugs 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 1
- 229940046413 calcium iodide Drugs 0.000 abstract 1
- 229910001640 calcium iodide Inorganic materials 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- RBNWAMSGVWEHFP-UHFFFAOYSA-N cis-p-Menthan-1,8-diol Natural products CC(C)(O)C1CCC(C)(O)CC1 RBNWAMSGVWEHFP-UHFFFAOYSA-N 0.000 abstract 1
- 229960002126 creosote Drugs 0.000 abstract 1
- 229960001700 domiodol Drugs 0.000 abstract 1
- NEIPZWZQHXCYDV-UHFFFAOYSA-N domiodol Chemical compound OCC1COC(CI)O1 NEIPZWZQHXCYDV-UHFFFAOYSA-N 0.000 abstract 1
- 229960000533 dornase alfa Drugs 0.000 abstract 1
- 108010067396 dornase alfa Proteins 0.000 abstract 1
- 229960002561 eprazinone Drugs 0.000 abstract 1
- BSHWLCACYCVCJE-UHFFFAOYSA-N eprazinone Chemical compound C=1C=CC=CC=1C(OCC)CN(CC1)CCN1CC(C)C(=O)C1=CC=CC=C1 BSHWLCACYCVCJE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003262 erdosteine Drugs 0.000 abstract 1
- QGFORSXNKQLDNO-UHFFFAOYSA-N erdosteine Chemical compound OC(=O)CSCC(=O)NC1CCSC1=O QGFORSXNKQLDNO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001867 guaiacol Drugs 0.000 abstract 1
- 229950010370 guaiacol carbonate Drugs 0.000 abstract 1
- ORUJFMPWKPVXLZ-UHFFFAOYSA-N guaiacol carbonate Chemical compound COC1=CC=CC=C1OC(=O)OC1=CC=CC=C1OC ORUJFMPWKPVXLZ-UHFFFAOYSA-N 0.000 abstract 1
- 229950010751 guaiacol phosphate Drugs 0.000 abstract 1
- ADBFDJQRBQZXAB-UHFFFAOYSA-N guaiacol phosphate Chemical compound COC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)OC)OC1=CC=CC=C1OC ADBFDJQRBQZXAB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002146 guaifenesin Drugs 0.000 abstract 1
- 235000019382 gum benzoic Nutrition 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 229960001178 iodinated glycerol Drugs 0.000 abstract 1
- 229960005208 ipecacuanha Drugs 0.000 abstract 1
- 229960004870 letosteine Drugs 0.000 abstract 1
- IKOCLISPVJZJEA-UHFFFAOYSA-N letosteine Chemical compound CCOC(=O)CSCCC1NC(C(O)=O)CS1 IKOCLISPVJZJEA-UHFFFAOYSA-N 0.000 abstract 1
- 229960001185 levoverbenone Drugs 0.000 abstract 1
- 229960000274 lysozyme Drugs 0.000 abstract 1
- 235000010335 lysozyme Nutrition 0.000 abstract 1
- 239000004325 lysozyme Substances 0.000 abstract 1
- 229960001155 mecysteine hydrochloride Drugs 0.000 abstract 1
- 229960004635 mesna Drugs 0.000 abstract 1
- 229960003652 neltenexine Drugs 0.000 abstract 1
- SSLHKNBKUBAHJY-HDJSIYSDSA-N neltenexine Chemical compound C1C[C@@H](O)CC[C@@H]1NCC1=CC(Br)=CC(Br)=C1NC(=O)C1=CC=CS1 SSLHKNBKUBAHJY-HDJSIYSDSA-N 0.000 abstract 1
- 229930006948 p-menthane-3,8-diol Natural products 0.000 abstract 1
- QFRKWSPTCBGLSU-UHFFFAOYSA-M potassium 4-hydroxy-3-methoxybenzene-1-sulfonate Chemical compound [K+].COC1=CC(S([O-])(=O)=O)=CC=C1O QFRKWSPTCBGLSU-UHFFFAOYSA-M 0.000 abstract 1
- 229940069505 potassium guaiacolsulfonate Drugs 0.000 abstract 1
- 229960004839 potassium iodide Drugs 0.000 abstract 1
- 229940048730 senega Drugs 0.000 abstract 1
- 229960000230 sobrerol Drugs 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 229960001790 sodium citrate Drugs 0.000 abstract 1
- 235000009518 sodium iodide Nutrition 0.000 abstract 1
- 229940083599 sodium iodide Drugs 0.000 abstract 1
- 229960000353 stepronin Drugs 0.000 abstract 1
- JNYSEDHQJCOWQU-UHFFFAOYSA-N stepronin Chemical compound OC(=O)CNC(=O)C(C)SC(=O)C1=CC=CS1 JNYSEDHQJCOWQU-UHFFFAOYSA-N 0.000 abstract 1
- RBNWAMSGVWEHFP-WAAGHKOSSA-N terpin Chemical compound CC(C)(O)[C@H]1CC[C@@](C)(O)CC1 RBNWAMSGVWEHFP-WAAGHKOSSA-N 0.000 abstract 1
- 229950010257 terpin Drugs 0.000 abstract 1
- 229960004402 tiopronin Drugs 0.000 abstract 1
- OMDMTHRBGUBUCO-UHFFFAOYSA-N trans-sobrerol Natural products CC1=CCC(C(C)(C)O)CC1O OMDMTHRBGUBUCO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1014391.5A GB201014391D0 (en) | 2010-08-27 | 2010-08-27 | Drug composition and its use in therapy |
| PCT/GB2011/051610 WO2012025761A1 (en) | 2010-08-27 | 2011-08-25 | Theobromine in combination with an expectorant or a mucolytic for use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ607670A true NZ607670A (en) | 2015-06-26 |
Family
ID=43013412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ607670A NZ607670A (en) | 2010-08-27 | 2011-08-25 | Theobromine in combination with an expectorant or a mucolytic for use in therapy |
Country Status (20)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
| GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| JP2017527618A (ja) * | 2014-09-08 | 2017-09-21 | ゴッサム バイオファーマシューティカルズ，インコーポレイティド | 肺サルコイドーシスの治療方法 |
| CN108601755B (zh) * | 2015-09-09 | 2021-08-10 | 韩国生命工学研究院 | 用于预防或治疗肌无力相关疾病的、包含水合蒎醇的组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9700654A2 (hu) * | 1997-03-26 | 1999-09-28 | Dezső Korbonits | Teobromin tartalmú köhögéscsillapító készítmények |
| AU4699299A (en) * | 1998-06-26 | 2000-01-17 | Nutracorp Scientific, Inc. | Promoting nitric oxide and cyclic gmp activity |
| JP2002193839A (ja) * | 2000-12-27 | 2002-07-10 | Meiji Seika Kaisha Ltd | ココア製剤 |
| JP2003055258A (ja) * | 2001-08-16 | 2003-02-26 | Rohto Pharmaceut Co Ltd | 安定化された組成物 |
| US7097859B2 (en) * | 2004-04-05 | 2006-08-29 | Hack Jacob C | Indium supplement compositions and methods therefor |
| US20060148837A1 (en) * | 2005-01-04 | 2006-07-06 | Everett Laboratories, Inc. | Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| GB2424185B (en) * | 2005-03-16 | 2009-12-30 | Atulkumar Sumanbhai Patel | A cough mixture |
| KR20080009994A (ko) * | 2006-07-25 | 2008-01-30 | 안국약품 주식회사 | 기침 치료용 조성물 |
| US20080085312A1 (en) * | 2006-10-04 | 2008-04-10 | Auriga Laboratories, Inc. | Multi-Phase Release Potassium Guaiacolsulfonate Compositions |
| WO2008089260A2 (en) * | 2007-01-16 | 2008-07-24 | Victory Pharma, Inc. | Combined administration of benzonatate and guaifenesin |
| DE102007000521A1 (de) * | 2007-10-18 | 2009-04-23 | Renate Conrad | Hustenpräparat |
| GB0910375D0 (en) * | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
| WO2011146031A1 (en) * | 2010-05-18 | 2011-11-24 | Bilgic Mahmut | Pharmaceutical composition comprising n- acetylcysteine and a xanthine |
-
2010
- 2010-08-27 GB GBGB1014391.5A patent/GB201014391D0/en not_active Ceased
-
2011
- 2011-08-25 JP JP2013526551A patent/JP2013536257A/ja active Pending
- 2011-08-25 WO PCT/GB2011/051610 patent/WO2012025761A1/en not_active Ceased
- 2011-08-25 AU AU2011294905A patent/AU2011294905B2/en not_active Ceased
- 2011-08-25 UA UAA201303724A patent/UA112760C2/uk unknown
- 2011-08-25 NZ NZ607670A patent/NZ607670A/en not_active IP Right Cessation
- 2011-08-25 SG SG2013014816A patent/SG188322A1/en unknown
- 2011-08-25 PE PE2013000352A patent/PE20140013A1/es not_active Application Discontinuation
- 2011-08-25 PH PH1/2013/500392A patent/PH12013500392A1/en unknown
- 2011-08-25 CA CA2809767A patent/CA2809767A1/en not_active Abandoned
- 2011-08-25 PL PL11755105T patent/PL2608847T3/pl unknown
- 2011-08-25 EA EA201390287A patent/EA201390287A1/ru unknown
- 2011-08-25 BR BR112013004659A patent/BR112013004659A8/pt not_active IP Right Cessation
- 2011-08-25 MX MX2013002334A patent/MX343598B/es active IP Right Grant
- 2011-08-25 CN CN201180052248.7A patent/CN103189108B/zh not_active Expired - Fee Related
- 2011-08-25 ES ES11755105.1T patent/ES2672128T3/es active Active
- 2011-08-25 EP EP11755105.1A patent/EP2608847B1/en not_active Not-in-force
-
2013
- 2013-02-27 IL IL224953A patent/IL224953A/en not_active IP Right Cessation
- 2013-03-22 CO CO13057476A patent/CO6700840A2/es unknown
- 2013-03-25 EC ECSP13012524 patent/ECSP13012524A/es unknown
-
2016
- 2016-08-04 JP JP2016153321A patent/JP2016196504A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013536257A (ja) | 2013-09-19 |
| ES2672128T3 (es) | 2018-06-12 |
| EP2608847A1 (en) | 2013-07-03 |
| GB201014391D0 (en) | 2010-10-13 |
| BR112013004659A2 (pt) | 2016-08-02 |
| AU2011294905B2 (en) | 2015-01-15 |
| ECSP13012524A (es) | 2013-05-31 |
| JP2016196504A (ja) | 2016-11-24 |
| BR112013004659A8 (pt) | 2018-01-02 |
| CO6700840A2 (es) | 2013-06-28 |
| CA2809767A1 (en) | 2012-03-01 |
| EP2608847B1 (en) | 2018-03-21 |
| UA112760C2 (uk) | 2016-10-25 |
| PL2608847T3 (pl) | 2018-08-31 |
| PH12013500392A1 (en) | 2013-05-27 |
| WO2012025761A1 (en) | 2012-03-01 |
| MX2013002334A (es) | 2013-03-18 |
| CN103189108B (zh) | 2017-02-08 |
| SG188322A1 (en) | 2013-04-30 |
| PE20140013A1 (es) | 2014-01-24 |
| MX343598B (es) | 2016-11-11 |
| CN103189108A (zh) | 2013-07-03 |
| EA201390287A1 (ru) | 2013-07-30 |
| AU2011294905A1 (en) | 2013-03-21 |
| IL224953A (en) | 2016-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Skyschally et al. | Ischemic postconditioning: experimental models and protocol algorithms | |
| RU2013156463A (ru) | Бритвенный картридж с контактирующим с кожей элементом | |
| JP2006298933A5 (cg-RX-API-DMAC10.html) | ||
| CL2008000975A1 (es) | Célula de planta de girasol resistente a herbicida que comprende dos alelos de resistencia a herbicida diferentes de la proteína ahasl1; metodo para combatir la vegetacion no deseada; kit para determinar el genotipo de dichas plantas con modificaciones en los alelos ahasl. | |
| CL2012000225A1 (es) | Concentrado herbicida acuoso de clopiralida (clopyralid), concentrada, de baja viscosidad y estable al almacenamiento, que comprende agua y la sal dimetilamina de clopiralida en una concentracion entre 600-850 gramos de acido equivalente por litro (gae/lt). | |
| RU2010153904A (ru) | Ниацин-содержащие композиции с модифицированным высвобождением | |
| JP2013536257A5 (cg-RX-API-DMAC10.html) | ||
| JP6087064B2 (ja) | 金属の防食処理方法 | |
| WO2008133157A1 (ja) | 体温低下抑制剤 | |
| Frederick et al. | The histopathological and biochemical response of the stomach of male F344/N rats following two weeks of oral dosing with ethyl acrylate | |
| Sohn et al. | Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia | |
| BR112012027953A2 (pt) | estrutura com um corpo flutuante para uma embarcação submarina bem como um método para construção de uma estrutura | |
| UY30677A1 (es) | Una dispersion acuosa y su uso para el tratamiento antimoho de quesos con corteza | |
| Checoni | Experimental study of the excess molar volume of ternary mixtures containing {water+(1, 2-propanediol, or 1, 3-propanediol, or 1, 2-butanediol, or 1, 3-butanediol, or 1, 4-butanediol, or 2, 3-butanediol)+ electrolytes} at a temperature of 298.15 K and atmospheric pressure | |
| CN216106756U (zh) | 一种耐酸耐腐蚀离型膜胶片 | |
| CN219539968U (zh) | 一种包覆式防腐型搅拌桨 | |
| Himes | The Kalamian microgroup of Philippine languages | |
| Galić et al. | Impact of the COVID-19 Pandemic on the most Popular Recreational Sports in Croatia-Football, Tennis and Running | |
| CN205403608U (zh) | 一种加强组合型捷克盾牌 | |
| AR044800A1 (es) | Sales de potasio y/o sodio del acido (-)-2-{[2-(4-hidroxifenil)etil]tio}-3-[4-(2-{4-[(metilsulfonil)oxi]fenoxi}etil)fenil] propanoico | |
| Radaš et al. | The role of core stability in lumbar discomfort and performance among young swimmers | |
| CN202559347U (zh) | 一种带薄膜的阻燃型空心纤维增强塑料锚杆 | |
| CN201489772U (zh) | 一种逃生指示器 | |
| TH84658A (th) | สารละลายตัวเร่งแบบเสถียรต่อการเก็บ | |
| BR0303882A (pt) | Agentes biológicos, ecologicamente corretos, para combate de pragas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: INFIRST HEALTHCARE LIMITED, GB Effective date: 20141106 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 25 AUG 2018 BY OLCOTT Effective date: 20151128 |
|
| LAPS | Patent lapsed |